Retraction Watch

Tracking retractions as a window into the scientific process

Weekend reads: More Impact Factor scrutiny; $10 million fine for overbilling; protected Canadian fraudsters

with one comment

booksThe week at Retraction Watch featured the loss of a Harvard researcher’s PhD for misconduct, and the harrowing tale of a whistleblower. Here’s what was happening elsewhere:

The Impact Factor will soon belong to private equity and money management firms, as Thomson Reuters announces it will sell its Intellectual Property & Science business for $3.55 billion. That was one of a number of items on Impact Factor this week:

And there was plenty of other material:

Like Retraction Watch? Consider making a tax-deductible contribution to support our growth. You can also follow us on Twitter, like us on Facebook, add us to your RSS reader, sign up on our homepage for an email every time there’s a new post, or subscribe to our new daily digest. Click here to review our Comments Policy. For a sneak peek at what we’re working on, click here.

Written by Ivan Oransky

July 16th, 2016 at 9:30 am

Posted in weekend reads

  • Anonymous July 16, 2016 at 9:54 am

    Regarding President Obama’s JAMA paper, Howard C. Bauchner, the journal’s editor in chief, states: “This paper definitely underwent peer review, and obviously we don’t fact-check every fact.”

  • Post a comment

    Threaded commenting powered by interconnect/it code.